CBAY: CymaBay Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

CymaBay Therapeutics, Inc.

NASDAQ:CBAY

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$32.48
Loss Chance
59.6%
0.12JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Amylyx Pharmaceuticals
NASDAQ:AMLX
1.66
$13.29
100.00%
Amphastar Pharmaceuticals
NASDAQ:AMPH
5.41
$16.87
75.56%
Bristol-Myers Squibb Company
NYSE:BMY
6.42
$57.00
1.92%
Collegium Pharmaceutical
NASDAQ:COLL
5.69
$33.78
90.27%
Corcept Therapeutics
NASDAQ:CORT
4.53
$56.37
385.31%
Jitta Factors
Growth Opportunity (25)
Recent Business Performance (62)
Financial Strength (37)
Return to Shareholders (0)
Competitive Advantage (15)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.12
100.00%
2.15
398.64%
2.15
398.64%
COMPANY DESCRIPTION
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta for the treatments of primary biliary cholangitis (PBC). The company also develops MBX-2982, a G protein-coupled receptor 119 (GPR119) agonist, in subjects with type 1 diabetes. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Fremont, California. As of March 22, 2024, CymaBay Therapeutics, Inc. operates as a subsidiary of Gilead Sciences, Inc.
www.cymabay.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.